en · de · es · pt
cjc-1295-notes.peptides3081.com › Faq › Receptor Action And Pharmacokinetics — Evidence Review

Receptor Action And Pharmacokinetics — Evidence Review

By Editorial Desk · published 2025-11-18 · last reviewed 2025-12-21 · Faq

This is a working overview of MOD GRF(1-29), written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2025-12-21. Anything still debated is marked as such rather than presented as settled.

Receptor Action and Pharmacokinetics

CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.

The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.

Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.

Background and Naming Conventions

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.

The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.

Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.

Cjc-1295 at a glance

PropertyValueNotes
Primary targetGHRH receptorG-protein-coupled receptor on pituitary somatotrophs
Half-life, long-acting formSeveral daysExtended by covalent albumin binding
Half-life, short formAbout 30 minutesCleared rapidly by peptidases and kidneys
Route in studiesSubcutaneous injectionUsed in the published human trials
Main measured effectRise in GH and IGF-1Surrogate markers rather than clinical endpoints

Background and Receptor Mechanism

CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.

Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.

Related pages on this site

Persistence, Stability and Measurement

The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.

Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.

Reference notes

==== United Kingdom ==== The UK National Health Service (NHS) recommends that people at risk of vitamin D deficiency, breast-fed babies, formula-fed babies taking no more than 500 ml of infant formula a day, and children aged 6 months to 4 years, should take daily vitamin D supplements throughout the year to ensure sufficient intake. This includes people with limited skin synthesis of vitamin D, who are not often outdoors, are frail, housebound, living in a care home, or usually wearing clothes that cover up most of the skin, or with dark skin, such as having an African, African-Caribbean or south Asian background. Other people may be able to make adequate vitamin D from sunlight exposure from April to September. The NHS and Public Health England recommend that everyone, including those who are pregnant and breastfeeding, consider taking a daily supplement containing 10 μg (400 IU) of vitamin D during autumn and winter because of inadequate sunlight for vitamin D synthesis.

The UN Single Convention provided a legal framework, and in 1988, the Convention against Illicit Traffic expanded that framework, working the US-style punitive approach into international law. By the end of Reagan's presidency in 1989, illicit drugs were more readily available and cheaper than at the start of his first term in 1981.

=== Pore canals === In all eggs, the embryo must breathe. In egg-laying amniotes (including dinosaurs), pore canals cutting through the eggshell allow gas exchange between the embryo and the outside world. Dinosaur eggshells exhibit a lot of diversity in pore size, density, and shape. One early attempt at classification of dinosaurian eggs, proposed by the Soviet paleontologist A. Sochava, was based on grouping eggs by their pore systems. This system was abandoned when it was discovered that different eggs could have very similar pores, but pore systems continue to play an important role in modern eggshell parataxonomy. The density and width of the pores, combined with the eggshell's thickness can be used to predict the gas conductance of a dinosaur's egg. This can provide both information about nesting behavior and about the climate: eggs buried in sediment have higher rates of gas conductance than those laid in the open, and eggs laid in arid environments have lower gas conductance (to prevent water loss) than those laid in more humid conditions. Paleontologist and fossil egg expert Kenneth Carpenter catalogued six types of pore systems:

Sources: en.wikipedia.org

Notes from published material

This is an option only when the cancer is superficial and infects only the bottom third of the ureter. The procedure entails removing the segment of cancerous ureter and reattaching the end. Patients with advanced bladder cancer or disease, also often look to bladder reconstruction as a treatment. Current methods of bladder reconstruction include the use of gastrointestinal tissue. However, while this method is effective in improving the function of the bladder, it can actually increases the risk of cancer, and can cause other complications, such as infections, urinary stones, and electrolyte imbalance. Therefore, other methods loom in the future. For example, current research paves the way for use of pluripotent stem cells to derive urothelium, as they are highly and indefinitely proliferative in vitro (i.e. outside of the body).

== The syndrome == MMF was originally described as a syndrome, with myalgia, arthralgia, marked asthenia, muscle weakness and fever as symptoms. Patients tend to have elevated creatine kinase, erythrocyte sedimentation rate, and a myopathic electromyograph.

== Bibliography == Agoncillo, Teodoro C. (1990) [1960]. History of the Filipino People (8th ed.). Quezon City: Garotech Publishing. ISBN 971-8711-06-6. Bautista, Alberto Manuel (1952). The Hukbalahap Movement in the Philippines, 1942-1952. University of California. Greenberg, Lawrence M. (1987). "V. Ramon Magsaysay, Edwards Landsdale, and the Jusmag". The Hukbalahap Insurrection: A Case Study of a Successful Anti-Insurgency Operation in the Philippines, 1946–1955. United States Army Center of Military History. Library of Congress Catalog Card Number: 86-600597. Archived from the original on May 21, 2011. Retrieved August 12, 2008. Greenberg, Lawrence M. (1987). "VI. The Insurrection – Phase II (1950–1955)". The Hukbalahap Insurrection: A Case Study of a Successful Anti-Insurgency Operation in the Philippines, 1946–1955. United States Army Center of Military History. Library of Congress Catalog Card Number: 86-600597. Archived from the original on May 21, 2011. Retrieved August 12, 2008. Martinez, Manuel F. (2002). "Mission Possible: Assassinate Quezon – and Mrs. Quezon". Assassinations and Conspiracies: From Rajah Humabon to Imelda Marcos. Pasig: Anvil Publishing, Inc. pp. 138–152. ISBN 971-27-1218-4. McClintock, Michael (1992). "4. Toward a New Counterinsurgency: Philippines, Laos, Vietnam". Instruments of Statecraft: U.S. Guerella Warfare, Counterinsurgency, and Counterterrorism, 1940-1990. Pantheon Books. Valeriano, Napoleon D. "Military Operations". Counter-Guerrilla Seminar Fort Bragg, 15 June 1961.

Sources: en.wikipedia.org

Further detail

=== Body image === Many women regard their breasts as important to their sexual attractiveness, as a sign of femininity that is important to their sense of self. A woman with smaller breasts may regard her breasts as less attractive.

=== Renal function === A 2019 systematic review published by the National Kidney Foundation investigated whether creatine supplementation had adverse effects on renal function. They identified 15 studies from 1997 to 2013 that looked at standard creatine loading and maintenance protocols of 4–20 g/day of creatine versus placebo. They utilized serum creatinine, creatinine clearance, and serum urea levels as a measure of renal damage. While in general creatine supplementation resulted in slightly elevated creatinine levels that remained within normal limits, supplementation did not induce renal damage (P value< 0.001). Special populations included in the 2019 Systematic review included type 2 diabetic patients and post-menopausal women, bodybuilders, athletes, and resistance trained populations. The study also discussed 3 case studies where there were reports that creatine affected renal function. In a joint statement between the American College of Sports Medicine, Academy of Nutrition and Dietetics, and Dietitians in Canada on performance enhancing nutrition strategies, creatine was included in their list of ergogenic aids and they do not list renal function as a concern for use. The most recent position stand on creatine from the Journal of International Society of Sports Nutrition states that creatine is safe to take in healthy populations from infants to the elderly to performance athletes. They also state that long term (5 years) use of creatine has been considered safe.

Recently, The Sur lab has shown that cortical astrocytes transform phasic norepinephrine reward prediction signals into prolonged calcium responses critical for behavioral optimization, and hence play an instrumental role in reinforcement learning (Drummond et al., bioRxiv 2026). These studies have thus contributed fundamentally to the view that astrocytes are not only partners with neurons but even have unique roles in information processing, plasticity and learning.

Sources: en.wikipedia.org

Frequently asked questions

How does CJC-1295 raise growth hormone levels?

It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.

Why does the DAC form last longer?

The drug affinity complex links the peptide to serum albumin through a covalent bond. The conjugate is too large to be filtered quickly by the kidneys and is shielded from enzymatic breakdown. This extends the apparent half-life from roughly minutes to several days.

What remains uncertain about its effects?

Long-term safety and any clinical benefit are unestablished. Published human data cover small groups over limited periods and focus on hormone levels rather than health outcomes. Whether prolonged elevation of growth hormone and insulin-like growth factor 1 is beneficial or harmful is an open question.

Does this compound occur naturally in the body?

No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.

Network